IL83059A - Stable hydrate of cephalosporin derivative,process for the preparation thereof and a gelatin capsule composition containing the same - Google Patents

Stable hydrate of cephalosporin derivative,process for the preparation thereof and a gelatin capsule composition containing the same

Info

Publication number
IL83059A
IL83059A IL83059A IL8305987A IL83059A IL 83059 A IL83059 A IL 83059A IL 83059 A IL83059 A IL 83059A IL 8305987 A IL8305987 A IL 8305987A IL 83059 A IL83059 A IL 83059A
Authority
IL
Israel
Prior art keywords
preparation
composition containing
same
gelatin capsule
capsule composition
Prior art date
Application number
IL83059A
Other languages
English (en)
Other versions
IL83059A0 (en
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP61156954A external-priority patent/JP2544113B2/ja
Priority claimed from JP21626086A external-priority patent/JPH0717651B2/ja
Application filed by Shionogi & Co filed Critical Shionogi & Co
Publication of IL83059A0 publication Critical patent/IL83059A0/xx
Publication of IL83059A publication Critical patent/IL83059A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicinal Preparation (AREA)
IL83059A 1986-07-02 1987-07-01 Stable hydrate of cephalosporin derivative,process for the preparation thereof and a gelatin capsule composition containing the same IL83059A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP61156954A JP2544113B2 (ja) 1986-07-02 1986-07-02 安定なカプセル製剤
JP21626086A JPH0717651B2 (ja) 1986-09-12 1986-09-12 経口投与用セフアロスポリン水和物結晶

Publications (2)

Publication Number Publication Date
IL83059A0 IL83059A0 (en) 1987-12-31
IL83059A true IL83059A (en) 1992-03-29

Family

ID=26484565

Family Applications (1)

Application Number Title Priority Date Filing Date
IL83059A IL83059A (en) 1986-07-02 1987-07-01 Stable hydrate of cephalosporin derivative,process for the preparation thereof and a gelatin capsule composition containing the same

Country Status (27)

Country Link
US (2) US4812561A (de)
KR (1) KR950005302B1 (de)
CN (1) CN1015106B (de)
AR (1) AR243893A1 (de)
AT (1) AT392472B (de)
AU (1) AU594167B2 (de)
BE (1) BE1001691A4 (de)
CA (1) CA1283405C (de)
CH (1) CH672788A5 (de)
DE (1) DE3721913A1 (de)
DK (1) DK161080C (de)
ES (2) ES2004952A6 (de)
FI (1) FI89052C (de)
FR (1) FR2601014B1 (de)
GB (1) GB2192183B (de)
GR (1) GR871014B (de)
HK (1) HK47893A (de)
HU (1) HU200777B (de)
IE (1) IE59613B1 (de)
IL (1) IL83059A (de)
IT (1) IT1211469B (de)
NL (1) NL193136C (de)
NO (1) NO170889C (de)
NZ (1) NZ220764A (de)
PL (1) PL159180B1 (de)
RU (1) RU1829932C (de)
SE (1) SE466257B (de)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5089270A (en) * 1990-05-15 1992-02-18 L. Perrigo Company Capsule-shaped tablet
US5599557A (en) * 1992-04-30 1997-02-04 Schering Corporation Stable hydrated cephalosporin dry powder for oral suspension formulation
JP2002528575A (ja) * 1998-10-27 2002-09-03 イーストマン ケミカル カンパニー オレフィンの重合方法、新規ポリエチレン並びにそれから製造されるフィルム及び物品
US6565882B2 (en) * 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
AT412213B (de) * 2000-05-30 2004-11-25 Sandoz Ag Verfahren zur trocknung von amoxicillin oder amoxicillin-hältigen, oralen, festen pharmazeutischen zusammensetzungen unter verwendung eines gases mit einer definierten gasfeuchte
US6541014B2 (en) * 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
US20020068078A1 (en) * 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US20020197314A1 (en) * 2001-02-23 2002-12-26 Rudnic Edward M. Anti-fungal composition
US7842791B2 (en) * 2002-12-19 2010-11-30 Nancy Jean Britten Dispersible pharmaceutical compositions
EP1648415A4 (de) * 2003-07-21 2011-11-16 Middlebrook Pharmaceuticals Inc Antibiotisches produkt, seine verwendung und formulierung
EP1648418A4 (de) * 2003-07-21 2011-11-16 Middlebrook Pharmaceuticals Inc Antibiotisches produkt, seine verwendung und formulierung
CA2533292C (en) * 2003-07-21 2013-12-31 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
WO2005016311A1 (en) * 2003-08-11 2005-02-24 Advancis Pharmaceutical Corporation Robust pellet
CA2535398C (en) * 2003-08-12 2013-11-12 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
EP1658034A4 (de) * 2003-08-29 2011-06-22 Middlebrook Pharmaceuticals Inc Antibiotisches produkt, seine verwendung und formulierung
WO2005027877A1 (en) * 2003-09-15 2005-03-31 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
AU2004308419B2 (en) * 2003-12-24 2011-06-02 Victory Pharma, Inc. Enhanced absorption of modified release dosage forms
US8715727B2 (en) * 2004-07-02 2014-05-06 Shionogi Inc. Tablet for pulsed delivery
US20110104109A1 (en) * 2005-07-13 2011-05-05 Frank Bennett Tetracyclic indole derivatives and their use for treating or preventing viral infections
EP1948179A1 (de) 2005-11-11 2008-07-30 Boehringer Ingelheim International GmbH Chinazolin-derivate zur behandlung von krebserkrankungen
US8778924B2 (en) * 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8299052B2 (en) * 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
AR062927A1 (es) * 2006-10-11 2008-12-17 Bayer Healthcare Ag 4- [4-( [ [ 4- cloro-3-( trifluorometil) fenil) carbamoil] amino] -3- fluorofenoxi) -n- metilpiridin-2- carboxamida monohidratada
CA2674831A1 (en) 2006-12-22 2008-11-13 Schering Corporation 5,6-ring annulated indole derivatives and methods of use thereof
MX2009006880A (es) 2006-12-22 2009-07-03 Schering Corp Derivados indolicos con anillo unido en las posiciones 4,5 para tratar o prevenir infecciones virales por virus de la hepatitis c e infecciones virales relacionadas.
JP5211068B2 (ja) * 2006-12-22 2013-06-12 メルク・シャープ・アンド・ドーム・コーポレーション Ｈｃｖおよび関連するウイルス疾患の治療または予防のための４，５−環インドール誘導体
CA2697500A1 (en) 2007-08-29 2009-03-12 Schering Corporation 2,3-substituted azaindole derivatives for treating viral infections
EP2197842B1 (de) * 2007-08-29 2012-05-23 Schering Corporation 2,3-substituierte indolderivate zur behandlung von virusinfektionen
ES2447543T3 (es) * 2007-08-29 2014-03-12 Merck Sharp & Dohme Corp. Derivados de indol sustituidos y métodos de utilización de los mismos
CA2705586A1 (en) * 2007-11-16 2009-05-22 Schering Corporation 3-heterocyclic substituted indole derivatives and methods of use thereof
EP2222672B1 (de) * 2007-11-16 2013-12-18 Merck Sharp & Dohme Corp. 3-aminosulfonylsubstituierte indolderivate und verfahren zu deren anwendung
WO2009152200A1 (en) * 2008-06-13 2009-12-17 Schering Corporation Tricyclic indole derivatives and methods of use thereof
TW201020245A (en) 2008-08-20 2010-06-01 Schering Corp Ethynyl-substituted pyridine and pyrimidine derivatives and their use in treating viral infections
ES2439009T3 (es) 2008-08-20 2014-01-21 Merck Sharp & Dohme Corp. Derivados de piridina y pirimidina sustituidos con etenilo y su uso en el tratamiento de infecciones virales
WO2010022126A1 (en) 2008-08-20 2010-02-25 Schering Corporation Azo-substituted pyridine and pyrimidine derivatives and their use in treating viral infections
CA2734486A1 (en) 2008-08-20 2010-02-25 Southern Research Institute Substituted pyridine and pyrimidine derivatives and their use in treating viral infections
CA2763140A1 (en) 2009-05-29 2010-12-02 Schering Corporation Antiviral compounds composed of three linked aryl moieties to treat diseases such as hepatitis c
PL2451445T3 (pl) 2009-07-06 2019-09-30 Boehringer Ingelheim International Gmbh Sposób suszenia BIBW2992, jego soli i stałych preparatów farmaceutycznych zawierających tę substancję czynną
AU2010324871A1 (en) 2009-11-25 2012-06-14 Merck Sharp & Dohme Corp. Fused tricyclic compounds and derivatives thereof useful for the treatment of viral diseases
CA2785488A1 (en) 2009-12-22 2011-07-21 Merck Sharp & Dohme Corp. Fused tricyclic compounds and methods of use thereof for the treatment of viral diseases
US9433621B2 (en) 2010-02-18 2016-09-06 Merck Sharp & Dohme Corp. Substituted pyridine and pyrimidine derivatives and their use in treating viral infections
EP2545060B1 (de) 2010-03-09 2015-11-25 Merck Sharp & Dohme Corp. Kondensierte tricyclische silylverbindngen und verfahren zu deren verwendung zur behandlung von viralen krankheiten
WO2011139253A2 (en) 2010-05-04 2011-11-10 Mahmut Bilgic Pharmaceutical compositions comprising ceftibuten
WO2012018534A2 (en) 2010-07-26 2012-02-09 Schering Corporation Substituted biphenylene compounds and methods of use thereof for the treatment of viral diseases
EP2621279B1 (de) 2010-09-29 2018-04-04 Merck Sharp & Dohme Corp. Kondensierte tetrazyklische derivate und verfahren zu ihrer verwendung zur behandlung von virenerkrankungen
US9156872B2 (en) 2011-04-13 2015-10-13 Merck Sharp & Dohme Corp. 2′-azido substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
EP2696681B1 (de) 2011-04-13 2018-10-03 Merck Sharp & Dohme Corp. 2'-substituierte nukleosidderivate und verfahren zu ihrer verwendung zur behandlung von virenerkrankungen
WO2013033899A1 (en) 2011-09-08 2013-03-14 Merck Sharp & Dohme Corp. Substituted benzofuran compounds and methods of use thereof for the treatment of viral diseases
WO2013033901A1 (en) 2011-09-08 2013-03-14 Merck Sharp & Dohme Corp. Heterocyclic-substituted benzofuran derivatives and methods of use thereof for the treatment of viral diseases
WO2013033900A1 (en) 2011-09-08 2013-03-14 Merck Sharp & Dohme Corp. Tetracyclic heterocycle compounds and methods of use thereof for the treatment of viral diseases
WO2013039876A1 (en) 2011-09-14 2013-03-21 Merck Sharp & Dohme Corp. Silyl-containing heterocyclic compounds and methods of use thereof for the treatment of viral diseases
WO2013151518A1 (en) * 2012-04-04 2013-10-10 Mahmut Bilgic Capsule formulations comprising ceftibuten
EP2815743A1 (de) 2013-06-21 2014-12-24 Sanovel Ilac Sanayi ve Ticaret A.S. Formulierungen mit Ceftibuten
US10167298B2 (en) 2013-10-30 2019-01-01 Merck Sharp & Dohme Corp. Pseudopolymorphs of an HCV NS5A inhibitor and uses thereof
US9242965B2 (en) 2013-12-31 2016-01-26 Boehringer Ingelheim International Gmbh Process for the manufacture of (E)-4-N,N-dialkylamino crotonic acid in HX salt form and use thereof for synthesis of EGFR tyrosine kinase inhibitors
CN103948932B (zh) * 2014-04-17 2016-03-16 海南日中天制药有限公司 一种头孢克肟组合物及其制备方法
EP3031450A1 (de) 2014-12-12 2016-06-15 Sanovel Ilac Sanayi ve Ticaret A.S. Ceftibutenkapselzusammensetzungen
CA3022684A1 (en) 2016-05-13 2017-11-16 Aeromics, Inc. Crystals
MY196909A (en) 2016-06-30 2023-05-09 Qpex Biopharma Inc Boronic acid derivatives and therapeutic uses thereof
CN106397454B (zh) * 2016-08-30 2018-08-24 山东罗欣药业集团股份有限公司 一种抗感染药物头孢布烯晶型化合物及其组合物
CN106432270A (zh) * 2016-09-21 2017-02-22 临沂草之美医药科技有限公司 一种制备治疗外科手术感染的药物头孢布烯晶体化合物的方法
CN106397457A (zh) * 2016-09-21 2017-02-15 临沂草之美医药科技有限公司 一种治疗外科手术感染的药物头孢布烯晶体化合物
CN106432272A (zh) * 2016-09-21 2017-02-22 临沂草之美医药科技有限公司 一种制备治疗外科手术感染的药物头孢布烯晶体化合物的方法
CN106432271A (zh) * 2016-09-21 2017-02-22 临沂草之美医药科技有限公司 一种治疗外科手术感染的药物头孢布烯晶体化合物
US12552815B2 (en) 2020-05-05 2026-02-17 Qpex Biopharma, Inc. Boronic acid derivatives and synthesis, polymorphic forms, and therapeutic uses thereof
US20240327426A1 (en) * 2021-07-01 2024-10-03 Qpex Biopharma, Inc. Crystalline forms of ceftibuten

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3819620A (en) * 1972-06-01 1974-06-25 Squibb & Sons Inc 7-(d-alpha-amino-1,4-cyclohexadien-1-ylacet-amido)desacetoxycephalosporanic acid dihydrate
JPS5726692A (en) * 1980-07-22 1982-02-12 Fujisawa Pharmaceut Co Ltd Preparation of stable crystal of salt of ceftizoxime
DE3037997A1 (de) * 1980-10-08 1982-05-13 Bayer Ag (beta) -lactamantibiotika, verfahren zu deren herstellung sowie sie enthaltende mittel
YU44680B (en) * 1982-07-30 1990-12-31 Glaxo Lab Ltd Process for obtaining very pure amorphous form of cephuroxim axetile
AU575854B2 (en) * 1983-10-04 1988-08-11 Shionogi & Co., Ltd. 7beta-(carboxyalkenamido) cephalosporins
AU580855B2 (en) * 1985-03-29 1989-02-02 Shionogi & Co., Ltd. Alkeneamidocephalosporin esters

Also Published As

Publication number Publication date
HK47893A (en) 1993-05-27
PL159180B1 (pl) 1992-11-30
KR950005302B1 (ko) 1995-05-23
GR871014B (en) 1987-11-02
FR2601014B1 (fr) 1990-09-14
KR880001670A (ko) 1988-04-26
IT1211469B (it) 1989-11-03
CH672788A5 (de) 1989-12-29
ES2004952A6 (es) 1989-02-16
GB8715064D0 (en) 1987-08-05
PL266567A1 (en) 1988-07-21
DK161080C (da) 1991-11-11
FI872903A0 (fi) 1987-07-01
AU7504087A (en) 1988-01-07
GB2192183B (en) 1990-05-16
ES2008759A6 (es) 1989-08-01
FI89052C (fi) 1993-08-10
IL83059A0 (en) 1987-12-31
BE1001691A4 (fr) 1990-02-13
IE871738L (en) 1988-01-02
SE8702705L (sv) 1988-01-03
HU200777B (en) 1990-08-28
DE3721913A1 (de) 1988-01-07
NL8701507A (nl) 1988-02-01
IE59613B1 (en) 1994-03-09
ATA165887A (de) 1990-09-15
NZ220764A (en) 1989-09-27
AU594167B2 (en) 1990-03-01
NO872729L (no) 1988-01-04
DK336487D0 (da) 1987-06-30
RU1829932C (ru) 1993-07-23
CN1015106B (zh) 1991-12-18
CN87105009A (zh) 1988-03-23
CA1283405C (en) 1991-04-23
FI872903L (fi) 1988-01-03
HUT44257A (en) 1988-02-29
US4812561A (en) 1989-03-14
IT8767566A0 (it) 1987-07-01
FR2601014A1 (fr) 1988-01-08
NL193136C (nl) 1998-12-04
NO170889C (no) 1992-12-23
SE8702705D0 (sv) 1987-06-30
DK161080B (da) 1991-05-27
US4933443A (en) 1990-06-12
NL193136B (nl) 1998-08-03
FI89052B (fi) 1993-04-30
NO170889B (no) 1992-09-14
NO872729D0 (no) 1987-06-30
AR243893A1 (es) 1993-09-30
GB2192183A (en) 1988-01-06
DK336487A (da) 1988-01-03
AT392472B (de) 1991-04-10
SE466257B (sv) 1992-01-20

Similar Documents

Publication Publication Date Title
IL83059A0 (en) Stable cephalosporin derivatives,process for the preparation thereof and a gelatine capsule composition containing the same
LTIP656A (en) Derivatives of 3-amidopyrazole, process for preparing thereof and pharmaceutical composition containing them
HUT50139A (en) Process for producing new triazol derivatives and antifungal pharmaceutical compositions containing them
PT79714A (en) Process for preparing novel derivatives of guanine and of pharmaceutical compositions containing the same
PT79783A (en) Process for preparing novel glycerine derivatives and of pharmaceutical compositions containing the same
PT76460A (en) Process for preparing novel cephalosporin derivatives and of pharmaceutical compositions containing the same
PT86516A (en) Process for the preparation of heteroaryl-3-oxo-propani-nitrile derivatives and of pharmaceutical compositions containing the same
PT86365A (en) Process for the preparation of pyridazodiazepine derivatives and of pharmaceutical compositions containing the same
PT76809A (en) Process for preparing 1-sulfo-2-oxoazetidine derivatives and of pharmaceutical compositions containing the same
PT80246A (en) Process for the preparation of novel cephalosporin derivatives and of pharmaceutical compositions containing the same
ZA885781B (en) Alkylaminoalkoxyphenyl derivatives,process of preparation and compositions containing the same
PT75100A (en) Process for the preparation of soft gelatine capsules containing ergod alcaloid
PT76330B (en) Process for preparing novel cephalosporin derivatives and of pharmaceutical compositions containing the same
PT84923A (en) Process for the preparation of 1-(hydroxystyrul)-5h-2,3-benzodiapezine derivatives and pharmaceutical compositions containing the same
PT78778B (en) Process for preparing novel thiazolidine derivatives and of pharmaceutical compositions containing the same
PT85337A (en) Process for the preparation of cycloalkyl-substituted 4-pyridil derivatives and of pharmaceutical compositions containing the same
DE3271383D1 (en) Ascochlorin derivatives; process for preparing the same and pharmaceutical composition containing the same
PT79199B (en) Process for preparing 3-indolecarboxamide derivatives and of pharmaceutical compositions containing the same
HUT37625A (en) Process for production of derivatives os 4,5,6,7-tetrahydro-tiazolo /5-h-c/ piridin and medical preparatives containing as reagent such compounds
PT84466B (en) Process for preparing aryl-azolylmethyl-benzocycloalkene derivatives and of pharmaceutical and fungicidal compositions containing the same
PT76557B (en) Process for preparing furan derivatives and addition salts thereof and of pharmaceutical compositions containing the same
HU895817D0 (en) Process for the preparation of phenyloxy-propanol-amine derivatives and pharmaceutical compositions containing them
EP0322765A3 (en) New thiazolidine derivatives, process for preparing same and anti-amnestic composition containing same
PT86297A (en) Process for preparing aryloxybenzeneacetic acid derivatives and of pharmaceutical compositions containing the same
HU891560D0 (en) Process for the preparation of pharmaceutical compositions containing quinoline derivatives

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired